MedBuzz:
In this episode of Oncology Unscripted, John Marshall, MD, discusses a troubling week in health care news, including upheaval at the FDA, concerns about reduced federal support for medical education, and growing evidence that AI-generated fabricated references are appearing in published scientific literature.

Main Topic:
In this episode of Oncology Unscripted, Dr John Marshall previews the practice-changing data expected at ASCO 2026, highlighting advances in precision medicine. Tune in to hear which presentations could shape the next wave of cancer care.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

MedBuzz:
In this episode of Oncology Unscripted MedBuzz, Dr Marshall discusses evolving rectal cancer data and the growing role of genomic testing. He also reflects on US science policy and concerns about instability, and the need to modernize clinical trials while protecting independent oversight and patient data.

Main Topic:
In this episode of Oncology Unscripted, Dr Marshall discusses the growing role of precision medicine in oncology and how it is shifting from an optional tool to a standard part of cancer care, including the increasing importance of MRD and ctDNA, and promise of blood-based cancer screening.

Interview:
In this episode of Candid Conversations , Dr. John Marshall speaks with Dr. Marija Balic of UPMC and the University of Pittsburgh about MRD ctDNA testing in early breast cancer.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

MedBuzz:
In this MedBuzz, Dr John Marshall discusses Steve Ubl’s departure from PhRMA and what it may signal for drug pricing, pharmaceutical policy, payer dynamics, and patient access.

Main Topic:
In this episode of Oncology Unscripted, Dr John Marshall explores the growing role of AI in cancer care, from analyzing patient data and predicting treatment responses to supporting clinical trials, guidelines, manuscripts, and patient communication. He also reflects on the risks of AI, including privacy, bias, accountability, energy demands, and the potential loss of human connection in medicine.

Interview:
In this expert panel discussion of Oncology Unscripted, Dr John Marshall explores how artificial intelligence is being used in health care today and where it may be headed next. Guests Neel Trivedi, MD; Ross Filice, MD; and Torbjørn Furuseth, MD, discuss AI scribes, radiology, digital pathology, clinical decision-making, patient privacy, and the ongoing role of human judgment in medicine.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.